UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021334
Receipt number R000024465
Scientific Title Gene analysis for insulin gene disorders
Date of disclosure of the study information 2016/03/04
Last modified on 2024/03/13 10:11:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Gene analysis for insulin gene disorders

Acronym

Gene analysis for insulin gene

Scientific Title

Gene analysis for insulin gene disorders

Scientific Title:Acronym

Gene analysis for insulin gene

Region

Japan


Condition

Condition

Insulin gene mutations

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Performing the insulin gene analysis to patient and their parents suspected of insulin gene abnormality

Basic objectives2

Others

Basic objectives -Others

gene analysis

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

presence or absence of insulin gene mutations

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Gene

Interventions/Control_1

taking blood samples

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patient and their parents suspected of insulin gene abnormality

Key exclusion criteria

except for patient and their parents suspected of insulin gene abnormality

Target sample size

3


Research contact person

Name of lead principal investigator

1st name Junko
Middle name
Last name Kanno

Organization

Tohoku University School of Medicine

Division name

Department of Pediatrics

Zip code

9800872

Address

1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan

TEL

+81-22-717-7287

Email

junkokan@ya2.so-net.ne.jp


Public contact

Name of contact person

1st name Akiko
Middle name
Last name Hakoda

Organization

Tohoku University School of Medicine

Division name

Department of Pediatrics

Zip code

9800872

Address

1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan

TEL

+81-22-717-7287

Homepage URL


Email

akos@mub.biglobe.ne.jp


Sponsor or person

Institute

Department of Pediatrics
Tohoku University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Pediatrics
Tohoku University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University School of Medicine

Address

1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan

Tel

022-717-7287

Email

akiko.hakoda.c2@tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 04 Day

Date of IRB

2016 Year 02 Month 22 Day

Anticipated trial start date

2016 Year 02 Month 22 Day

Last follow-up date

2017 Year 03 Month 07 Day

Date of closure to data entry

2017 Year 03 Month 07 Day

Date trial data considered complete

2017 Year 03 Month 07 Day

Date analysis concluded

2017 Year 03 Month 07 Day


Other

Other related information



Management information

Registered date

2016 Year 03 Month 04 Day

Last modified on

2024 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024465


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name